Literature DB >> 1372558

Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis.

T Olsson1, J Sun, J Hillert, B Höjeberg, H P Ekre, G Andersson, O Olerup, H Link.   

Abstract

Myelin basic protein (MBP)-autoreactive T cells have a crucial pathogenetic role in experimental allergic encephalomyelitis (EAE) and certain MBP epitopes may be immunodominantly recognized. The heterogeneity and quantity of the T cell response to different epitopes of MBP in multiple sclerosis (MS) and non-MS controls is not so clearly defined. We now study T cell reactivity to six different peptides of MBP in MS compared to controls in short-term cultures of blood mononuclear cells by measuring numbers of T cells that secrete interferon-gamma in response to antigen. In comparison with controls, MS patients showed dramatically increased numbers of MBP peptide-reactive T cells with mean values varying between 10.4 and 22.5 per 10(5) blood mononuclear cells. Among those MBP peptides examined (amino acid 1-20, 63-88, 89-101, 96-118, 110-128 and 148-165), no single peptide is preferentially recognized. Neither is any preferential response apparent after subdivision of the MS patients according to their HLA-DR genotype. Our findings suggest that a quantitative increase of a broad repertoire of myelin-autoreactive T cells with capacity to secrete IFN-gamma can be important for the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372558     DOI: 10.1002/eji.1830220431

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

1.  A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis.

Authors:  M Bakhiet; V Ozenci; C Withagen; M Mustafa; S Fredrikson; H Link
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 2.  Major histocompatibility complex molecules on parenchymal cells of the target organ protect against autoimmune disease.

Authors:  Hui Shao; Henry J Kaplan; Deming Sun
Journal:  Chem Immunol Allergy       Date:  2007

3.  Influence of T-cell receptor genes on chronic experimental autoimmune encephalomyelitis.

Authors:  L Jansson; T Olsson; R Holmdahl
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 4.  Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies.

Authors:  Ai-Lan Nguyen; Melissa Gresle; Tessa Marshall; Helmut Butzkueven; Judith Field
Journal:  Br J Pharmacol       Date:  2017-04-26       Impact factor: 8.739

5.  Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis.

Authors:  J Ludovic Croxford; Julie K Olson; Holly A Anger; Stephen D Miller
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.

Authors:  P A Muraro; M Vergelli; M Kalbus; D E Banks; J W Nagle; L R Tranquill; G T Nepom; W E Biddison; H F McFarland; R Martin
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

7.  Anti-class II MHC antibodies prevent and treat EAE without APC depletion.

Authors:  R M Smith; A Morgan; D C Wraith
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

8.  TCRB-V gene usage in monozygotic twins discordant for multiple sclerosis.

Authors:  M P Roth; J Riond; E Champagne; S Essaket; A Cambon-Thomsen; J Clayton; M Clanet; H Coppin
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.

Authors:  E A Elliott; H I McFarland; S H Nye; R Cofiell; T M Wilson; J A Wilkins; S P Squinto; L A Matis; J P Mueller
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

10.  B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.

Authors:  Tomasz Brudek; Tove Christensen; Lars Aagaard; Thor Petersen; Hans J Hansen; Anné Møller-Larsen
Journal:  Retrovirology       Date:  2009-11-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.